Sexual Risk Behaviors among African Americans Who Use MDMA (Molly/Ecstasy): Implications for HIV Prevention

Khary K Rigg1, Alexandra Mills2

  • 1Department of Mental Health Law & Policy, Louis de la Parte Florida Mental Health Institute, University of South Florida , Tampa, Florida, USA.

Insights

Sexual risk-taking, including unprotected sex and group sex, is common among African Americans who use 3,4-methylenedioxymethamphetamine (MDMA). The context and mindset during MDMA use contribute to these behaviors.

Area of Science:

  • Public Health
  • Sociology
  • Substance Abuse Research

Background:

  • Recreational 3,4-methylenedioxymethamphetamine (MDMA) use is linked to sexual risk-taking behaviors.
  • Limited research exists on sexual risk behaviors among African American MDMA users due to historical underrepresentation in studies.

Purpose of the Study:

  • To describe the patterns and prevalence of sexual risk behaviors among African Americans who use MDMA.
  • To explore the role of MDMA and the nightlife environment in contributing to these behaviors.

Main Methods:

  • Utilized survey data to identify and quantify sexual risk behaviors in Black MDMA users.
  • Incorporated qualitative interview data to provide context on MDMA's influence and environmental factors.

Main Results:

  • Sexual risk-taking behaviors, such as unprotected sex, casual encounters, sex while on MDMA, and group sex, were found to be prevalent.
  • The mindset and consumption context associated with MDMA use were identified as contributing factors.

Conclusions:

  • This study addresses a critical gap in understanding MDMA use and sexual risk among African Americans.
  • Findings can inform HIV prevention strategies for this population and highlight the importance of contextual factors.

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
731
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.9K
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
476
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
734
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
124
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
735